Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
China
· Delayed Price · Currency is CNY 11.45
+0.55 (5.05%)
Mar 10, 2026, 3:04 PM CST
SHE:002898 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,918 | 1,693 | 2,459 | 2,138 | 1,839 | 1,647 | Upgrade
|
| Market Cap Growth | 7.07% | -31.14% | 14.98% | 16.27% | 11.64% | -25.82% | Upgrade
|
| Enterprise Value | 2,005 | 1,776 | 2,529 | 2,215 | 1,915 | 1,706 | Upgrade
|
| Last Close Price | 10.90 | 9.62 | 13.94 | 12.12 | 10.43 | 9.34 | Upgrade
|
| PE Ratio | - | - | 257.90 | - | - | - | Upgrade
|
| Forward PE | - | 53.89 | 53.89 | 53.89 | 53.89 | 53.89 | Upgrade
|
| PS Ratio | 7.84 | 6.42 | 7.92 | 8.09 | 7.44 | 13.65 | Upgrade
|
| PB Ratio | 4.17 | 3.39 | 4.59 | 4.06 | 3.26 | 2.81 | Upgrade
|
| P/TBV Ratio | 4.91 | 3.92 | 5.24 | 4.66 | 3.73 | 3.22 | Upgrade
|
| P/FCF Ratio | - | - | 479.45 | - | 461.13 | - | Upgrade
|
| P/OCF Ratio | - | - | 68.86 | 151.40 | 51.87 | 9430.41 | Upgrade
|
| EV/Sales Ratio | 8.19 | 6.74 | 8.14 | 8.38 | 7.75 | 14.14 | Upgrade
|
| EV/EBITDA Ratio | - | 194.11 | 54.64 | - | 342.75 | - | Upgrade
|
| EV/EBIT Ratio | - | - | 188.96 | - | - | - | Upgrade
|
| EV/FCF Ratio | -26.35 | - | 493.11 | - | 480.25 | - | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.33 | 0.24 | 0.27 | 0.31 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | - | 14.71 | 2.74 | - | 25.42 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 24.85 | - | 43.39 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.19 | 0.23 | 0.07 | 0.14 | 0.11 | 0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.44 | 12.71 | 0.83 | -7.61 | 10.69 | -1.31 | Upgrade
|
| Net Debt / FCF Ratio | -1.14 | -1.58 | 7.44 | -7.25 | 14.98 | -0.97 | Upgrade
|
| Asset Turnover | 0.30 | 0.33 | 0.37 | 0.31 | 0.29 | 0.15 | Upgrade
|
| Inventory Turnover | 2.28 | 1.93 | 2.24 | 2.19 | 1.50 | 0.80 | Upgrade
|
| Quick Ratio | 0.37 | 0.60 | 0.70 | 0.61 | 0.87 | 0.78 | Upgrade
|
| Current Ratio | 0.82 | 0.98 | 1.13 | 0.86 | 1.09 | 1.28 | Upgrade
|
| Return on Equity (ROE) | -14.12% | -6.40% | 1.80% | -6.85% | -4.06% | -10.79% | Upgrade
|
| Return on Assets (ROA) | -3.86% | -1.75% | 1.01% | -3.06% | -1.92% | -5.81% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.57% | -3.82% | 0.97% | -6.95% | -4.08% | -11.88% | Upgrade
|
| Return on Capital Employed (ROCE) | -10.40% | -4.10% | 2.30% | -7.70% | -4.20% | -12.30% | Upgrade
|
| Earnings Yield | -3.64% | -1.96% | 0.39% | -1.75% | -1.27% | -4.08% | Upgrade
|
| FCF Yield | -3.97% | -4.34% | 0.21% | -0.46% | 0.22% | -3.88% | Upgrade
|
| Dividend Yield | - | - | 0.14% | - | - | - | Upgrade
|
| Payout Ratio | - | - | 58.52% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.11% | -0.07% | 0.06% | 0.01% | -0.01% | -0.04% | Upgrade
|
| Total Shareholder Return | -0.11% | -0.07% | 0.20% | 0.01% | -0.01% | -0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.